BANK OF MONTREAL /CAN/ - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 163 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.5%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$428,000
+380.9%
27,827
+952.5%
0.00%
Q1 2021$89,000
-62.0%
2,644
-68.4%
0.00%
Q4 2020$234,000
+138.8%
8,355
+233.8%
0.00%
Q3 2020$98,000
-42.7%
2,503
-35.5%
0.00%
Q2 2020$171,000
+34.6%
3,880
-20.5%
0.00%
Q4 2019$127,000
+36.6%
4,880
+43.4%
0.00%
Q3 2019$93,000
+6.9%
3,402
+5.6%
0.00%
Q2 2019$87,0003,2230.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$45,386,0009.32%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$472,400,0005.23%
Wildcat Capital Management, LLC 1,515,524$38,252,0004.81%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 900,143$22,720,0003.28%
Coastal Bridge Advisors, LLC 385,824$9,738,0001.93%
Casdin Capital, LLC 945,000$23,852,0000.71%
DSAM Partners (London) Ltd 208,798$5,270,0000.62%
BAINCO INTERNATIONAL INVESTORS 152,839$3,858,0000.44%
Pier Capital, LLC 152,071$3,838,0000.41%
Woodline Partners LP 567,539$14,325,0000.38%
View complete list of ALLOGENE THERAPEUTICS INC shareholders